Ligand validation:6O4K

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 6O4K designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6O4K_NAD_G_601	59%	3%	0.102	0.954	4.81	1.39	8	3	0	0	61%	0.6136
6O4K_NAD_B_602	58%	3%	0.104	0.952	4.85	1.52	9	3	0	0	61%	0.2945
6O4K_NAD_D_601	53%	3%	0.116	0.946	4.93	1.48	8	2	0	0	61%	0.3068
6O4K_NAD_E_601	52%	3%	0.115	0.942	4.89	1.59	7	6	0	0	61%	0.6136
6O4K_NAD_H_601	51%	3%	0.117	0.941	4.82	1.41	8	3	0	0	61%	0.6136
6O4K_NAD_F_603	50%	3%	0.118	0.939	4.82	1.43	8	2	0	0	61%	0.3252
6O4K_NAD_C_601	50%	3%	0.118	0.938	4.92	1.46	9	3	1	0	61%	0.3191
6O4K_NAD_A_602	48%	3%	0.12	0.931	4.76	1.33	9	3	1	0	61%	0.6136
6O4C_NAD_G_601	94%	3%	0.069	0.97	4.99	1.35	16	4	1	0	100%	1
6O4B_NAD_H_601	93%	3%	0.074	0.968	5.16	1.22	15	4	1	0	100%	1
6O4E_NAD_D_601	87%	2%	0.092	0.964	5.15	1.41	16	6	1	0	100%	0.93
6O4L_NAD_A_604	87%	3%	0.095	0.966	5	1.25	15	5	1	0	100%	0.93
4X0T_NAD_B_601	84%	21%	0.108	0.97	2	1.35	14	6	0	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	10%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	16%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	7%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.